Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5,175 USD | +0,49% | -5,74% | -13,61% |
Omzet 2024 * | 397 mln. 367 mln. | Omzet 2025 * | 486 mln. 449 mln. | Marktkapitalisatie | 1,06 mld. 982 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -116 mln. -107 mln. | Nettowinst (verlies) 2025 * | -50 mln. -46,24 mln. | EV/omzet 2024 * | 3,26 x |
Nettoschuld 2024 * | 234 mln. 216 mln. | Nettoschuld 2025 * | 259 mln. 239 mln. | EV/omzet 2025 * | 2,72 x |
K/w-verhouding 2024 * |
-8,95
x | K/w-verhouding 2025 * |
-18,3
x | Werknemers | 536 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 96,92% |
Recentste transcriptie over BioCryst Pharmaceuticals, Inc.
1 dag | +0,49% | ||
1 week | -5,74% | ||
Lopende maand | -8,08% | ||
1 maand | -9,37% | ||
3 maanden | -15,02% | ||
6 maanden | -28,52% | ||
Lopend jaar | -13,61% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jon Stonehouse
CEO | Chief Executive Officer | 63 | 01-01-07 |
Anthony Doyle
DFI | Director of Finance/CFO | 44 | 02-04-20 |
Michael Jones
DFI | Director of Finance/CFO | 54 | 01-01-11 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Alan Levin
BRD | Director/Board Member | 62 | 27-02-20 |
Jon Stonehouse
CEO | Chief Executive Officer | 63 | 01-01-07 |
Director/Board Member | 60 | 26-07-21 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.23% | 0 M€ | 0,00% | - | |
0.20% | 0 M€ | 0,00% | - | |
0.18% | 907 M€ | +9,25% | - | |
0.13% | 464 M€ | -.--% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 5,17 | +0,39% | 317 875 |
27-03-24 | 5,15 | +2,79% | 2 990 374 |
26-03-24 | 5,01 | +2,04% | 3 159 988 |
25-03-24 | 4,91 | -2,00% | 2 828 319 |
22-03-24 | 5,01 | -8,74% | 3 296 041 |
uitgestelde koers Nasdaq, 28 maart 2024 om 14:58 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-13,61% | 1,06 mld. | |
+2,94% | 108 mld. | |
+9,90% | 104 mld. | |
+6,49% | 23,66 mld. | |
-11,23% | 22,1 mld. | |
-3,29% | 19,71 mld. | |
-35,98% | 18,2 mld. | |
-13,63% | 16,19 mld. | |
+4,08% | 13,72 mld. | |
+34,19% | 12,22 mld. |